DIN 02565161 — YORVIPATH 294 MCG
YORVIPATH is a solution of Palopegteriparatide marketed by PENDOPHARM DIVISION OF PHARMASCIENCE INC. The full Palopegteriparatide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02565161
- Brand name
- YORVIPATH
- Active ingredient
- Palopegteriparatide
- Strength
- 294 MCG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- PENDOPHARM DIVISION OF PHARMASCIENCE INC
- Health Canada status
- MARKETED
- Drug class
- Parathyroid hormone (PTH) analogue / replacement therapy
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Palopegteriparatide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02565188 | YORVIPATH | 420 MCG | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |